Laurence A. Turka Rubius Therapeutics, Inc. (RUBY) insider trading activity

RUBY Quotes by TradingView

Laurence A. Turka is Chief Scientific Officer of Rubius Therapeutics, Inc.. Currently has a direct ownership of 18,391 shares of RUBY, which is worth approximately $0. The most recent transaction as insider was on Jan 31, 2023, when has been sold 2,593 shares (Common Stock) at a price of $0.24 per share, resulting in proceeds of $622. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.4K
0% 3M change
0% 12M change
Total Value Held $0

Laurence A. Turka Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2023
SELL
Open market or private sale
$622 $0.24 p/Share
2,593 Reduced 12.36%
18,391 Common Stock
Jan 31 2023
BUY
Exercise of conversion of derivative security
-
8,625 Added 29.13%
20,984 Common Stock
Jan 29 2023
BUY
Exercise of conversion of derivative security
-
7,438 Added 37.57%
12,359 Common Stock
Feb 01 2022
SELL
Open market or private sale
$16,537 $6.57 p/Share
2,517 Reduced 33.84%
4,921 Common Stock
Jan 29 2022
BUY
Exercise of conversion of derivative security
-
7,438 Added 50.0%
7,438 Common Stock
LAT

Laurence A. Turka

Chief Scientific Officer
Cambridge, MA

Track Institutional and Insider Activities on RUBY

Follow Rubius Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RUBY shares.

Notify only if

Insider Trading

Get notified when an Rubius Therapeutics, Inc. insider buys or sells RUBY shares.

Notify only if

News

Receive news related to Rubius Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RUBY